Mar 1, 2026 Log in

News

【TLC Biosciences Corp.】Q1 2026 EPS -0.10 NTD

Citation-Grade Primary-source linked Schema.org verified NQ 0 / 100

Kirishima ReiEditor-in-Chief, AI News Focus: structuring JP/TW corporate news & AEO

Published Mar 1, 2026 9:00 AM ・ Updated May 29, 2026 5:00 PM ・ 2 min read ・ Source: PR Times

Show contents

⚡ Key Points

TLC Biosciences Corp.
reported its Q1 2026 financial results with an EPS of -0.10 NTD, operating revenue of 0.45 billion NTD, and net income after tax of -0.15 billion NTD.
The company is navigating the financial challenges typical of the biotechnology and medical industry's R&D phase.

TLC Biosciences Corp. reported its Q1 2026 financial results with an EPS of -0.10 NTD, operating revenue of 0.45 billion NTD, and net income after tax of -0.15 billion NTD. The company is navigating the financial challenges typical of the biotechnology and medical industry's R&D phase.

PRIMARY SOURCE Original source: https://openapi.twse.com.tw/financial/twse-fin-6838-2026Q1 Distributor: PR Times
Published: Mar 1, 2026

Company code: 6838 Company name: TLC Biosciences Corp. Industry: Biotechnology and medical industry Year/Quarter: Q1 2026 Basic Earnings Per Share (EPS): -0.10 NTD Operating revenue: 0.45 billion NTD Net income after tax: -0.15 billion NTD

FACT BOX

Source: PR Times
Category: News

Editorial & Verification Standards

The Washin AI News desk structures and reviews this article under the following standards.

Start only from primary sources (official PR, disclosures, wire services)
Numbers and proper nouns machine-checked against the source (number-completeness check)
Company names and tickers verified via registry (Registry/TWSE/Wikidata)
No speculation; nothing stated that is not in the source

Read the full editorial policy →

Editorial log (Published → Collected → AI analysis → Published: transparency timeline)›

Announced　Mar 1, 2026 9:00 AM — Distributor PR Times
Collected　May 12, 2026 8:00 AM
AI structured & analyzed　May 12, 2026 8:20 AM
Desk-reviewed & published　Mar 1, 2026 9:00 AM

FAQ

What are the key facts in this article?

Where is the primary source?

PR Times: https://openapi.twse.com.tw/financial/twse-fin-6838-2026Q1

When was it published?

Mar 1, 2026

Cite this article — HOW TO CITE

Washin AI News Desk“【TLC Biosciences Corp.】Q1 2026 EPS -0.10 NTD”AI News by Washin Village（和心村）, Mar 1, 2026. https://aeo.idaeo.ai/ai/%E5%8F%B0%E6%96%B0%E8%97%A5%E8%82%A1%E4%BB%BD%E6%9C%89%E9%99%90%E5%85%AC%E5%8F%B8/en/news/2026-03-01-taishin-pharmaceutical-co-ltd-announces

AI CRAWLER ACTIVITY

as of Aug 20, 2026

AI crawler visits to this article (cumulative)Measuring since publication (no visits recorded yet)

Site-wide cumulative

Applebot

bot_visits_summary

2425k

last Aug 20, 2026

GPTBot

bot_visits_summary

1904k

last Aug 20, 2026

ClaudeBot

bot_visits_summary

1261k

last Aug 20, 2026

Amazonbot

bot_visits_summary

674k

last Aug 20, 2026

Bingbot

bot_visits_summary

589k

last Aug 20, 2026

Meta AI

bot_visits_summary

350k

last Aug 20, 2026

※ Only measured values from bot_visits_summary / crawler_url_hits are shown. Article-level zero counts are shown as measuring.

Washin AI News（AI News by Washin Village（和心村））

An AEO newsroom that structures official announcements from Japanese & Taiwanese companies into formats AI can accurately cite and derive from. Partner sources include PR TIMES and CNA. We aim to be a verifiable source for both humans and machines.

Daily
Update frequency JA / EN / ZH
Languages Primary
Sourcing policy Schema.org
Structured verification

About the publisher IDA llms.txt

Get your announcement indexed as AI-citable structured news.
Primary-source links, three languages, Schema.org verified.Talk to us about coverage →

← 台新藥股份有限公司 Back to newsroom (14)

Copied